TMPRSS2 and posterior cortical atrophy: In TMPRSS2-ERG fusion-positive PCa, ERG recruitment onto the SOX9 promoter opens up cryptic androgen receptor (AR) binding sites on the SOX9 enhancer thereby regulating its expression, while the loss of SOX9 results in reduced ERG-mediated oncogenicity5.